Betaine-homocysteine Methyltransferase 742G>A Polymorphism and Risk of Down Syndrome Offspring in a Brazilian Population

Overview

Journal Mol Biol Rep

Specialty Molecular Biology

Date 2013 May 7

PMID 23645037

Citations 6

Authors

Marcia R Amorim

Claudia M Moura

Aline D Gomes

Hazel N Barboza

Roberta B Lopes

Marcia G Ribeiro

Marcelo A Costa Lima

Affiliations

Soon will be listed here.

Abstract

Down syndrome (DS) is the most common form of mental retardation of genetic etiology. Several polymorphisms in genes involved with the folic acid cycle have been associated to the risk of bearing a DS child; however, the results are controversial. Betaine-homocysteine methyltransferase (BHMT) is a key enzyme of folate pathway, and catalyzes the remethylation of homocysteine into methionine. Recent studies suggest that the polymorphism BHMT 742G>A may be associated with a decreased risk of having a DS child. We herein investigate the association of this polymorphism with the occurrence of DS in a Brazilian population. We have genotyped 94 mothers of DS infants (DSM) and 134 control mothers (CM) for this polymorphism through PCR-RFLP, and found significant differences for both BHMT 742G>A genotype (P=0.04) and allele (P=0.03) frequencies between DSM and CM. The observed genotypic frequencies were GG=0.45; GA=0.45 and AA=0.10 in CM, and GG=0.54; GA=0.38 and AA=0.02 in DSM. Allelic frequencies were G=0.68 and A=0.32 in CM and G=0.78 and A=0.22 in DSM. The presence of the mutant BHMT 742 A allele decreases 40% the risk of bearing a DS child (OR=0.61; 95% CI: 0.40-0.93; P=0.03), and the risk is diminished up to >80% in association with the homozygous genotype (OR=0.17; 95% CI: 0.04-0.80; P=0.01). Our results indicate that women harboring the single nucleotide polymorphism BHMT 742G>A have a decreased risk of a DS pregnancy, and further studies are necessary to confirm this protective effect.

Citing Articles

One-carbon metabolism and global DNA methylation in mothers of individuals with Down syndrome.

Mendes C, Zampieri B, Arantes L, Melendez M, Biselli J, Carvalho A Hum Cell. 2021; 34(6):1671-1681.

PMID: 34410622 DOI: 10.1007/s13577-021-00586-0.

Genetic Polymorphisms in Enzymes Involved in One-Carbon Metabolism and Anti-epileptic Drug Monotherapy on Homocysteine Metabolism in Patients With Epilepsy.

Zhu S, Ni G, Sui L, Zhao Y, Zhang X, Dai Q Front Neurol. 2021; 12:683275.

PMID: 34177787 PMC: 8220895. DOI: 10.3389/fneur.2021.683275.

Maternal Folate Status and the BHMT c.716G>A Polymorphism Affect the Betaine Dimethylglycine Pathway during Pregnancy.

Colomina J, Cavalle-Busquets P, Fernandez-Roig S, Sole-Navais P, Fernandez-Ballart J, Ballesteros M Nutrients. 2016; 8(10).

PMID: 27735840 PMC: 5084009. DOI: 10.3390/nu8100621.

Choline metabolic pathway gene polymorphisms and risk for Down syndrome: An association study in a population with folate-homocysteine metabolic impairment.

Jaiswal S, Sukla K, Chauhan A, Lakhotia A, Kumar A, Rai A Eur J Clin Nutr. 2016; 71(1):45-50.

PMID: 27677362 DOI: 10.1038/ejcn.2016.190.

Synthetic combinations of missense polymorphic genetic changes underlying Down syndrome susceptibility.

Jackson R, Nguyen M, Barrett A, Tan Y, Choolani M, Chen E Cell Mol Life Sci. 2016; 73(21):4001-17.

PMID: 27245382 PMC: 11108497. DOI: 10.1007/s00018-016-2276-0.

References

Zampieri B, Biselli J, Goloni-Bertollo E, Vannucchi H, Carvalho V, Cordeiro J . Maternal risk for Down syndrome is modulated by genes involved in folate metabolism. Dis Markers. 2012; 32(2):73-81. PMC: 3826801. DOI: 10.3233/DMA-2011-0869. View

Mostowska A, Myka M, Lianeri M, Roszak A, Jagodzinski P . Folate and choline metabolism gene variants and development of uterine cervical carcinoma. Clin Biochem. 2011; 44(8-9):596-600. DOI: 10.1016/j.clinbiochem.2011.02.007. View

Zintzaras E . Maternal gene polymorphisms involved in folate metabolism and risk of Down syndrome offspring: a meta-analysis. J Hum Genet. 2007; 52(11):943-953. DOI: 10.1007/s10038-007-0202-x. View

Lu S . S-Adenosylmethionine. Int J Biochem Cell Biol. 2000; 32(4):391-5. DOI: 10.1016/s1357-2725(99)00139-9. View

Hazra A, Wu K, Kraft P, Fuchs C, Giovannucci E, Hunter D . Twenty-four non-synonymous polymorphisms in the one-carbon metabolic pathway and risk of colorectal adenoma in the Nurses' Health Study. Carcinogenesis. 2007; 28(7):1510-9. DOI: 10.1093/carcin/bgm062. View

Mills J, Carter T, Kay D, Browne M, Brody L, Liu A . Folate and vitamin B12-related genes and risk for omphalocele. Hum Genet. 2011; 131(5):739-46. PMC: 3374579. DOI: 10.1007/s00439-011-1117-3. View

Zampieri B, Biselli J, Goloni-Bertollo E, Pavarino E . BHMT G742A and MTHFD1 G1958A polymorphisms and Down syndrome risk in the Brazilian population. Genet Test Mol Biomarkers. 2012; 16(6):628-31. DOI: 10.1089/gtmb.2011.0257. View

Barkai G, Arbuzova S, Berkenstadt M, Heifetz S, Cuckle H . Frequency of Down's syndrome and neural-tube defects in the same family. Lancet. 2003; 361(9366):1331-5. DOI: 10.1016/S0140-6736(03)13080-2. View

da Silva L, Galbiatti A, Ruiz M, Raposo L, Maniglia J, Pavarino E . MTHFD1 G1958A, BHMT G742A, TC2 C776G and TC2 A67G polymorphisms and head and neck squamous cell carcinoma risk. Mol Biol Rep. 2011; 39(2):887-93. DOI: 10.1007/s11033-011-0813-3. View

10.

Giusti B, Saracini C, Bolli P, Magi A, Sestini I, Sticchi E . Genetic analysis of 56 polymorphisms in 17 genes involved in methionine metabolism in patients with abdominal aortic aneurysm. J Med Genet. 2008; 45(11):721-30. DOI: 10.1136/jmg.2008.057851. View

11.

Zhu H, Curry S, Wen S, Wicker N, Shaw G, Lammer E . Are the betaine-homocysteine methyltransferase (BHMT and BHMT2) genes risk factors for spina bifida and orofacial clefts?. Am J Med Genet A. 2005; 135(3):274-7. DOI: 10.1002/ajmg.a.30739. View

12.

Morin I, Platt R, Weisberg I, Sabbaghian N, Wu Q, Garrow T . Common variant in betaine-homocysteine methyltransferase (BHMT) and risk for spina bifida. Am J Med Genet A. 2003; 119A(2):172-6. DOI: 10.1002/ajmg.a.20115. View

13.

Mostowska A, Hozyasz K, Wojcicki P, Dziegelewska M, Jagodzinski P . Associations of folate and choline metabolism gene polymorphisms with orofacial clefts. J Med Genet. 2009; 47(12):809-15. DOI: 10.1136/jmg.2009.070029. View

14.

Gueant J, Gueant-Rodriguez R, Anello G, Bosco P, Brunaud L, Romano C . Genetic determinants of folate and vitamin B12 metabolism: a common pathway in neural tube defect and Down syndrome?. Clin Chem Lab Med. 2003; 41(11):1473-7. DOI: 10.1515/CCLM.2003.226. View

15.

Pawlik P, Mostowska A, Lianeri M, Sajdak S, Kedzia H, Jagodzinski P . Folate and choline metabolism gene variants in relation to ovarian cancer risk in the Polish population. Mol Biol Rep. 2011; 39(5):5553-60. DOI: 10.1007/s11033-011-1359-0. View

16.

Boyles A, Wilcox A, Taylor J, Shi M, Weinberg C, Meyer K . Oral facial clefts and gene polymorphisms in metabolism of folate/one-carbon and vitamin A: a pathway-wide association study. Genet Epidemiol. 2008; 33(3):247-55. PMC: 2677659. DOI: 10.1002/gepi.20376. View

17.

Allen E, Freeman S, Druschel C, Hobbs C, OLeary L, Romitti P . Maternal age and risk for trisomy 21 assessed by the origin of chromosome nondisjunction: a report from the Atlanta and National Down Syndrome Projects. Hum Genet. 2008; 125(1):41-52. PMC: 2833410. DOI: 10.1007/s00439-008-0603-8. View

18.

James S, Pogribna M, Pogribny I, Melnyk S, Hine R, Gibson J . Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. Am J Clin Nutr. 1999; 70(4):495-501. DOI: 10.1093/ajcn/70.4.495. View

19.

McKeever M, Weir D, Molloy A, Scott J . Betaine-homocysteine methyltransferase: organ distribution in man, pig and rat and subcellular distribution in the rat. Clin Sci (Lond). 1991; 81(4):551-6. DOI: 10.1042/cs0810551. View

20.

Koushik A, Kraft P, Fuchs C, Hankinson S, Willett W, Giovannucci E . Nonsynonymous polymorphisms in genes in the one-carbon metabolism pathway and associations with colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2006; 15(12):2408-17. DOI: 10.1158/1055-9965.EPI-06-0624. View